Bayer recruits former Sanofi exec to lead US oncology business

Germany’s largest drugmaker Bayer (BAYN: DE) appointed Bhavesh Ashar as senior vice president and head of oncology for the company's Pharmaceuticals Division in the USA, reporting to Carsten Brunn, head of Bayer Pharmaceuticals for the Americas region.

"Bhavesh is a well-respected, results-driven leader with extensive industry knowledge and a proven track record of launching products and driving growth in oncology," said Mr Brunn, adding: "We are delighted to have Bhavesh join Bayer's US Pharmaceuticals organization. I'm confident that he will help to advance our growing leadership in oncology and our ongoing commitment to meeting the needs of people living with cancer."

Previously, Mr Ashar served as vice president and general manager of US oncology at French pharma major Sanofi (Euronext: SAN) and was responsible for managing a diverse portfolio comprising solid tumor, hematology and transplant products. Mr Ashar was with Sanofi for more than 14 years and held positions of increasing responsibility in sales and marketing, with a strong focus on specialty markets. Prior to joining Sanofi, Mr Ashar served as an engagement manager with McKinsey & Company.